Skip to main content
. 2022 May 1;11(9):2548. doi: 10.3390/jcm11092548

Table 2.

Comparison of analyzed parameters in the group of women with PCOS divided according to the value of HOMA-IR or BMI.

Parameters PCOS p Value
HOMA-IR < 2.0; n = 43 HOMA-IR ≥ 2.0; n = 17
SOD activity [U/L] 5.2 (4.7; 6.3) 4.7 (4.3; 5.5) 0.046
Zn [µg/L] 858.7 (769.7; 942.8) 818.3 (752.7; 920.7) NS
Cu [µg/L] 813.8 (724.1; 989.0) 958.1 (832.1; 1077.2) 0.012
Cu/Zn ratio 1.0 (0.9; 1.1) 1.1 (1.0; 1.2) 0.015
LH [lU/L] 5.8 (3.4; 9.1) 8.6 (5.6; 12.5) NS
FSH [lU/L] 5.8 (5.0; 7.0) 5.9 (5.2; 6.5) NS
FT4 [ng/dL] 1.2 (1.0; 1.3) 1.2 (1.0; 1.3) NS
TSH [mU/L] 1.9 (1.4; 2.9) 1.9 (1.3; 2.5) NS
SHBG [nmol/L] 70.0 (46.7; 86.6) 43.1 (22.8; 59.0) 0.004
Total testosterone [ng/mL] 0.4 (0.2; 0.4) 0.5 (0.4; 0.6) 0.016
Free testosterone [pg/mL] 1.6 (1.1; 2.4) 2.3 (1.2; 3.3) NS
Androstenedione [ng/mL] 2.5 (1.7; 3.5) 4.0 (2.6; 4.8) 0.024
17-β-E2 [pg/mL] 30.5 (21.5; 48.6) 37.8 (30.2; 50.5) NS
17-OHP [nmol/L] 1.7 (1.1; 1.9) 2.1 (1.6; 2.4) 0.037
BMI < 25.0; n = 40 BMI ≥ 25.0; n = 20
SOD activity [U/L] 5.6 (4.3; 6.5) 5.1 (4.5; 5.3) NS
Zn [µg/L] 867.6 (802.9; 942.8) 834.2 (733.1; 959.1) NS
Cu [µg/L] 859.2 (742.6; 1003.9) 852.3 (772.2; 1042.1) NS
Cu/Zn ratio 1.0 (0.9; 1.1) 1.0 (0.9; 1.3) NS
LH [lU/L] 5.9 (22.2; 50.4) 7.8 (3.4; 13.0) NS
FSH [lU/L] 6.4 (5.0; 7.1) 6.1 (5.1; 6.6) NS
FT4 [ng/dL] 1.2 (1.1; 1.4) 1.1 (1.0; 1.2) NS
TSH [mU/L] 1.8 (1.5; 2.5) 1.7 (1.2; 2.5) NS
SHBG [nmol/L] 76.3 (52.7; 93.4) 26.7 (17.1; 44.5) 0.001
Total testosterone [ng/mL] 0.3 (0.2; 0.4) 0.5 (0.4; 0.7) 0.001
Free testosterone [pg/mL] 1.6 (1.0; 2.2) 2.5 (1.3; 3.7) 0.005
Androstenedione [ng/mL] 2.6 (1.7; 3.5) 4.0 (1.8; 4.9) 0.038
17-β-E2 [pg/mL] 34.4 (22.2; 50.4) 36.6 (28.6; 51.8) NS
17-OHP [nmol/L] 1.6 (1.0; 2.0) 2.3 (1.6; 2.5) 0.030

Legend: Values shown as median (1st quartile, 3rd quartile); PCOS—polycystic ovary syndrome; SOD—superoxide dismutase; Zn—zinc; Cu—copper; LH—luteinizing hormone; FSH—follicle-stimulating hormone; FT4—free thyroxine; TSH—thyrotropin; SHBG—sex hormone-binding globulin; 17-β-E2—17-β-estradiol; 17-OHP—17-α-hydroxyprogesterone; NS—not significant.